2007 SUMMIT SPEAKERS
August 23, 24 and 25, 2007
Program Chair: Dr Stuart Kauffman
Schedule (pdf)

|
KEYNOTE: Dr Sui Huang
Assistant Professor of Surgery, Children’s Hospital Harvard Medical School |
Bio
Sui Huang is assistant professor at the Children’s Hospital / Harvard Medical School in Boston where he conducts research in “systems biology” of cell fate decisions in stem cells - with a focus on the blood system. More broadly, Dr Huang is interested in complex systems and the very fundamental principles of multi-cellularity, including its characteristic manifestations: cell differentiation and cancer. His research activities include cell experiments, bioinformatics and theoretical modeling to understand the high-dimensional dynamics of complex gene regulatory networks in cell fate regulation and the non-genetic, stochastic cell heterogeneity that plays a key role in cell lineage commitment and tumor progression. Dr Huang received his MD and his PhD in molecular genetics and physical chemistry from the University of Zurich, Switzerland. Before he joined the faculty at Harvard Medical School in 2004, he has worked on interferon, cell cycle regulation, angiogenesis and tumorigenesis. |

iCORE Chair & Professor Research Exchange Part I
To foster discussions and connections, each iCORE Chair/Professor or team, will present a brief overview of their current research. |
Chaired by Dr Randy Goebel
Order of presentations to be decided. |

|
KEYNOTE: Dr Bob Germain
Manager, Biomolecular Dynamics and Scalable Modeling Group, IBM Research |
Bio
Robert S. Germain manages the Biomolecular Dynamics and Scalable Modeling group within the Computational Biology Center at the IBM Thomas J. Watson Research Center. He received his AB in physics from Princeton University in 1982 and his MS and PhD in physics from Cornell University. After receiving his doctorate in 1989, Germain joined the Watson Research Center as a Research Staff Member in the Physical Sciences Department and later the VLSI/Scalable Parallel Systems Packaging Department. From 1995 to 1998, he was project leader for development of a large scale fingerprint identification system using an indexing scheme (FLASH) developed at IBM Research. Since 2000, Dr Germain has been responsible for the science and associated application portions of the Blue Gene project. His current research interests include the parallel implementation of algorithms for high performance scientific computing, the development of new programming models for parallel computing, and applications of high performance computing to challenging scientific problems in computational biology. Dr Germain is a member of the IEEE. the ACM, and the American Physical Society.
|

|
KEYNOTE: Dr Simon Kasif
Bioinformatics, Computational Genomics and Molecular Engineering, Bioinformatics and Biomedical Engineering, Boston University |
Bio
Dr Simon Kasif is a professor at Boston University where he conducts research in Bioinformatics, Computational Genomics and Molecular Engineering. He received his PhD in Computer Science from the University of Maryland, College Park. While at University of Maryland he co-designed and implemented the first parallel logic programming system that has been mapped to a real parallel processing system. In 1985 he joined the faculty of Johns Hopkins University where he helped form the Computer Science Department in 1986. After 11 years on faculty at Johns Hopkins, Dr Kasif moved to University of Illinois at Chicago. While at Johns Hopkins, he developed an active program in high performance intelligent systems, that included several major efforts in learning systems, parallel search systems, computational modeling systems for scientific applications and data mining. In 1992 Dr Kasif developed and helped draw attention to some of the first complex probabilistic models of computational biology. He also taught at the University of Maryland, College Park and Princeton University, performed research at NEC Research Institute, Weizmann Institute of Science and Tel-Aviv University and served as a consultant to industrial organizations. |

|
KEYNOTE: Dr Alexander Hartemink
Assistant Professor, Department of Computer Science, Duke University |
Bio
Alexander Hartemink is an assistant professor in the Department of Computer Science at Duke University. He is also affiliated with the Center for Bioinformatics and Computational Biology, which is part of Duke’s Institute for Genome Sciences and Policy. He has been at Duke since September 2001, when he received his PhD from the Department of Electrical Engineering and Computer Science at the Massachusetts Institute of Technology. His research interests are in computational systems biology and machine learning. Specifically, his work focuses on the development and application of new statistical learning algorithms to complex problems in systems biology. A number of common themes appear repeatedly throughout his work: probabilistic representations, Bayesian statistics, fusion of information from multiple sources, optimization of joint objective functions, and learning in high-dimensional spaces without overfitting. Many of these themes are variations on a single idea: the use of informative Bayesian priors to both regularize and guide automated learning.
|

iCORE Chair & Professor Research Exchange Part II
To foster discussions and connections, each iCORE Chair/Professor or team, will present a brief overview of their current research. |
iCORE Chairs and Professors present a brief description of their research.
Chaired by Dr Randy Goebel
Order of presentations to be decided. |

|
KEYNOTE: Dr Azra Raza
Clinical Hematology, University of Massachusetts |
Bio
Dr Raza is the Gladys Smith Martin Professor of Oncology, Professor of Medicine, Chief of Hematology and Associate Clinical Director of the Cancer Center at the University of Massachusetts (UMass), Worcester, MA. Dr Raza completed her medical education in Pakistan, training in Internal Medicine at the University of Maryland, Franklin Square Hospital and Georgetown/VA Medical Center in Washington, D.C. and her fellowship in Medical Oncology at Roswell Park Cancer Institute in Buffalo, New York. She started her research in Myelodysplastic Syndromes (MDS) in 1982, moved briefly to Cincinnati, Ohio and then to Chicago, Illinois in 1992, where she established a highly productive translational research program in MDS. This program, along with a Tissue Repository containing more than 40,000 samples from MDS patients was successfully relocated to UMass in 2004. Dr Raza has authored 230 full-length papers, 15 book chapters, 510 abstracts, and edited a book devoted to MDS. She has been the Director of a dynamic basic research laboratory, and sees approximately 4-500 new MDS patients a year at the Radhey Khanna MDS Center at UMass. There are 20+ clinical trials open for all stages of MDS patients at this center, including those with early stage MDS who are being offered treatment with natural substances. Over 200 MDS/AML patients are accrued on these Phase I-III clinical trials annually. Dr Raza serves on numerous National and International panels as a reviewer, consultant and advisor.
|
 |
|
|
|